Annual Long Term Debt
$48.88 M
-$5.46 M-10.05%
December 31, 2022
Summary
- As of February 8, 2025, EVLO annual long term debt is $48.88 million, with the most recent change of -$5.46 million (-10.05%) on December 31, 2022.
- During the last 3 years, EVLO annual long term debt has risen by +$29.25 million (+148.95%).
- EVLO annual long term debt is now -10.05% below its all-time high of $54.34 million, reached on December 31, 2021.
Performance
EVLO Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$0.00
-$3.88 M-100.00%
September 30, 2023
Summary
- As of February 8, 2025, EVLO quarterly long term debt is $0.00, with the most recent change of -$3.88 million (-100.00%) on September 30, 2023.
- Over the past year, EVLO quarterly long term debt has dropped by -$42.59 million (-100.00%).
- EVLO quarterly long term debt is now -100.00% below its all-time high of $55.41 million, reached on June 30, 2021.
Performance
EVLO Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
EVLO Long Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -10.1% | -100.0% |
3 y3 years | +148.9% | -100.0% |
5 y5 years | +390.5% | -100.0% |
EVLO Long Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -10.1% | at low | -100.0% | at low |
5 y | 5-year | -10.1% | +148.9% | -100.0% | at low |
alltime | all time | -10.1% | +392.2% | -100.0% | at low |
Evelo Biosciences Long Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2023 | - | $0.00(-100.0%) |
Jun 2023 | - | $3.88 M(-15.4%) |
Mar 2023 | - | $4.58 M(-90.6%) |
Dec 2022 | $48.88 M(-10.1%) | $48.88 M(+14.8%) |
Sep 2022 | - | $42.59 M(-10.0%) |
Jun 2022 | - | $47.31 M(-8.9%) |
Mar 2022 | - | $51.95 M(-4.4%) |
Dec 2021 | $54.34 M(+35.7%) | $54.34 M(-1.0%) |
Sep 2021 | - | $54.89 M(-0.9%) |
Jun 2021 | - | $55.41 M(+43.1%) |
Mar 2021 | - | $38.72 M(-3.3%) |
Dec 2020 | $40.04 M | $40.04 M(-1.0%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2020 | - | $40.43 M(+31.3%) |
Jun 2020 | - | $30.79 M(-1.2%) |
Mar 2020 | - | $31.17 M(+58.8%) |
Dec 2019 | $19.63 M(+59.6%) | $19.63 M(+0.4%) |
Sep 2019 | - | $19.55 M(+31.6%) |
Jun 2019 | - | $14.86 M(+42.1%) |
Mar 2019 | - | $10.46 M(-15.0%) |
Dec 2018 | $12.30 M(+23.5%) | $12.30 M(-13.1%) |
Sep 2018 | - | $14.15 M(-4.1%) |
Jun 2018 | - | $14.75 M(+0.2%) |
Mar 2018 | - | $14.72 M(+47.7%) |
Dec 2017 | $9.97 M(+0.4%) | $9.97 M |
Dec 2016 | $9.93 M | - |
FAQ
- What is Evelo Biosciences annual long term debt?
- What is the all time high annual long term debt for Evelo Biosciences?
- What is Evelo Biosciences annual long term debt year-on-year change?
- What is Evelo Biosciences quarterly long term debt?
- What is the all time high quarterly long term debt for Evelo Biosciences?
- What is Evelo Biosciences quarterly long term debt year-on-year change?
What is Evelo Biosciences annual long term debt?
The current annual long term debt of EVLO is $48.88 M
What is the all time high annual long term debt for Evelo Biosciences?
Evelo Biosciences all-time high annual long term debt is $54.34 M
What is Evelo Biosciences annual long term debt year-on-year change?
Over the past year, EVLO annual long term debt has changed by -$5.46 M (-10.05%)
What is Evelo Biosciences quarterly long term debt?
The current quarterly long term debt of EVLO is $0.00
What is the all time high quarterly long term debt for Evelo Biosciences?
Evelo Biosciences all-time high quarterly long term debt is $55.41 M
What is Evelo Biosciences quarterly long term debt year-on-year change?
Over the past year, EVLO quarterly long term debt has changed by -$42.59 M (-100.00%)